- Details
University of Leeds researcher is developing an IOL for presbyopia made from liquid crystal.
- Details
Citron Research accuses Canadian-based pharmaceutical company Valeant of massive fraud.
- Details
FDA has requested an additional information for Shire’s dry eye disease drug, lifitegrast.
- Details
Allergan Plc. has purchased AqueSys and its minimally invasive soft shunt for glaucoma, XEN45
Read more: Allergan acquires minimally invasive glaucoma shunt
- Details
Avedro has resubmitted a new drug application for its riboflavin opthalmic solution/KXL system for corneal cross-linking (CXL).
Read more: Avedro resubmits FDA application for CXL treatment
- Details
Dr. Sam Masket developed an IOL to prevent negative dysphotopsia, the dark or grey arc-shaped shadow seen in the temporal field of vision following uncomplicated cataract surgery.